REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $240,664 | -54.3% | 20,982 | +0.8% | 0.00% | -100.0% |
Q2 2023 | $526,625 | -32.6% | 20,807 | -14.2% | 0.00% | -50.0% |
Q1 2023 | $781,157 | -38.3% | 24,252 | -64.6% | 0.00% | -33.3% |
Q4 2022 | $1,266,042 | -57.8% | 68,583 | -38.2% | 0.00% | -66.7% |
Q3 2022 | $2,997,000 | +277.0% | 110,988 | +93.0% | 0.01% | +200.0% |
Q2 2022 | $795,000 | -59.4% | 57,498 | -42.7% | 0.00% | -50.0% |
Q1 2022 | $1,956,000 | +210.0% | 100,300 | +159.7% | 0.01% | +200.0% |
Q4 2021 | $631,000 | +45.1% | 38,620 | +147.6% | 0.00% | +100.0% |
Q3 2021 | $435,000 | -71.3% | 15,600 | -69.5% | 0.00% | -83.3% |
Q2 2021 | $1,514,000 | -18.3% | 51,091 | -21.9% | 0.01% | -25.0% |
Q4 2020 | $1,853,000 | +808.3% | 65,400 | +707.4% | 0.01% | +700.0% |
Q3 2020 | $204,000 | -61.8% | 8,100 | -62.3% | 0.00% | -66.7% |
Q3 2018 | $534,000 | +30.2% | 21,501 | +43.9% | 0.00% | +50.0% |
Q2 2018 | $410,000 | – | 14,939 | +373375.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 4 | -98.7% | 0.00% | – |
Q2 2015 | $10,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |